{
  "id": "7d46857029b0ae66",
  "title": "Ribo launches Hong Kong IPO Amid Optimism For siRNA Therapies",
  "description": "20260102T154500Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/Opinion/26/01/49665914/ribo-launches-hong-kong-ipo-amid-optimism-for-sirna-therapies",
  "published_at": "20260102T154500Z",
  "fetched_at": "2026-01-03T00:22:18.884957+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ipo"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/Opinion/26/01/49665914/ribo-launches-hong-kong-ipo-amid-optimism-for-sirna-therapies",
    "url_mobile": "",
    "title": "Ribo launches Hong Kong IPO Amid Optimism For siRNA Therapies",
    "seendate": "20260102T154500Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2026/01/02/-20260102193742-24-4.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}